Collegium Pharma (COLL) Reports In-Line Q4 EPS; Offers FY23 Revenue Guidance

Go back to Collegium Pharma (COLL) Reports In-Line Q4 EPS; Offers FY23 Revenue Guidance
(NASDAQ: COLL) Delayed: 21.82 -0.41 (1.84%)
Previous Close $22.23    52 Week High $30.58 
Open $22.14    52 Week Low $8.24 
Day High $22.33    P/E N/A 
Day Low $21.82    EPS $0.00 
Volume 811,564